$245 Million is the total value of Atika Capital Management LLC's 132 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | New | ISHARES TRput | $25,836,000 | – | 208,000 | +100.0% | 10.55% | – |
XBI | New | SPDR SERIES TRUSTput | $11,269,000 | – | 170,000 | +100.0% | 4.60% | – |
EW | New | EDWARDS LIFESCIENCES CORP | $4,099,000 | – | 34,000 | +100.0% | 1.67% | – |
DKS | New | DICKS SPORTING GOODS INC | $4,084,000 | – | 72,000 | +100.0% | 1.67% | – |
AERI | New | AERIE PHARMACEUTICALS INC | $3,774,000 | – | 100,000 | +100.0% | 1.54% | – |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $3,238,000 | – | 35,000 | +100.0% | 1.32% | – |
BGFV | New | BIG 5 SPORTING GOODS CORP | $2,888,000 | – | 212,000 | +100.0% | 1.18% | – |
CLCD | New | COLUCID PHARMACEUTICALS INC | $2,862,000 | – | 75,000 | +100.0% | 1.17% | – |
EXAS | New | EXACT SCIENCES CORP | $2,754,000 | – | 148,300 | +100.0% | 1.12% | – |
SEM | New | SELECT MED HLDGS CORP | $2,551,000 | – | 189,000 | +100.0% | 1.04% | – |
MDCO | New | MEDICINES CO | $2,453,000 | – | 65,000 | +100.0% | 1.00% | – |
RDUS | New | RADIUS HEALTH INC | $2,434,000 | – | 45,000 | +100.0% | 0.99% | – |
BIIB | New | BIOGEN INC | $2,347,000 | – | 7,500 | +100.0% | 0.96% | – |
SPWH | New | SPORTSMANS WHSE HLDGS INC | $2,314,000 | – | 220,000 | +100.0% | 0.94% | – |
RNG | New | RINGCENTRAL INCcl a | $2,082,000 | – | 88,000 | +100.0% | 0.85% | – |
ACXM | New | ACXIOM CORP | $1,999,000 | – | 75,000 | +100.0% | 0.82% | – |
ELF | New | E L F BEAUTY INC | $1,968,000 | – | 70,000 | +100.0% | 0.80% | – |
ELLI | New | ELLIE MAE INC | $1,895,000 | – | 18,000 | +100.0% | 0.77% | – |
INCR | New | INC RESH HLDGS INCcl a | $1,604,000 | – | 36,000 | +100.0% | 0.66% | – |
ALGN | New | ALIGN TECHNOLOGY INC | $1,593,000 | – | 17,000 | +100.0% | 0.65% | – |
TLND | New | TALEND S Aads | $1,387,000 | – | 53,000 | +100.0% | 0.57% | – |
EGHT | New | 8X8 INC NEW | $1,265,000 | – | 82,000 | +100.0% | 0.52% | – |
AXGT | New | AXOVANT SCIENCES LTD | $1,036,000 | – | 74,000 | +100.0% | 0.42% | – |
ARRY | New | ARRAY BIOPHARMA INC | $857,000 | – | 127,000 | +100.0% | 0.35% | – |
NTNX | New | NUTANIX INCcl a | $777,000 | – | 21,000 | +100.0% | 0.32% | – |
EXEL | New | EXELIXIS INC | $704,000 | – | 55,000 | +100.0% | 0.29% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MARTIN MARIETTA MATLS INC | 38 | Q3 2023 | 6.1% |
NETFLIX INC | 35 | Q2 2023 | 5.6% |
MICROSOFT CORP | 32 | Q3 2023 | 6.7% |
AMAZON COM INC | 29 | Q3 2023 | 8.6% |
LIBERTY MEDIA CORP DELAWARE | 29 | Q2 2023 | 5.3% |
META PLATFORMS INC | 25 | Q3 2023 | 5.8% |
INTUITIVE SURGICAL INC | 24 | Q3 2023 | 3.3% |
ARGENX SE | 23 | Q3 2023 | 1.6% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 5.1% |
EPAM SYS INC | 22 | Q3 2022 | 1.8% |
View Atika Capital Management LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Atika Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.